# NKGen Biotech, Inc. (NKGN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NKGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ 15.72M | $ -2.92M | $ 38.19M | $ -50.33M |
| 2024 | $ 685.3K | $ -46.55M | $ -21.95M | $ 0 | $ 0 |
| 2023 | $ 0 | $ -89.69M | $ -23.78M | $ 19.92M | $ -58.69M |
| 2022 | $ 3.4K | $ -7.77M | $ -7.22M | $ 12.03M | $ 1.56M |
| 2021 | $ 0 | $ -1.18M | $ -1.81M | $ 0 | $ 160.72M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.76 |
| Liabilities / Eq | -1.31 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/NKGN.md)
- [Charts](https://sponda.capital/en/NKGN/charts.md)
- [Compare](https://sponda.capital/en/NKGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.